Normal epithelial cells require matrix attachment for survival, and the ability of tumour cells to survive outside their natural extracellular matrix (ECM) niches is dependent on acquisition of anchorage independence 1 . Although apoptosis is the most rapid mechanism for eliminating cells lacking appropriate ECM attachment 2 , recent reports suggest that non-apoptotic death processes prevent survival when apoptosis is inhibited in matrix-deprived cells 3, 4 . Here we demonstrate that detachment of mammary epithelial cells from ECM causes an ATP deficiency owing to the loss of glucose transport. Overexpression of ERBB2 rescues the ATP deficiency by restoring glucose uptake through stabilization of EGFR and phosphatidylinositol-3-OH kinase (PI(3)K) activation, and this rescue is dependent on glucose-stimulated flux through the antioxidant-generating pentose phosphate pathway. Notably, we found that the ATP deficiency could be rescued by antioxidant treatment without rescue of glucose uptake. This rescue was found to be dependent on stimulation of fatty acid oxidation, which is inhibited by detachment-induced reactive oxygen species (ROS). The significance of these findings was supported by evidence of an increase in ROS in matrix-deprived cells in the luminal space of mammary acini, and the discovery that antioxidants facilitate the survival of these cells and enhance anchorage-independent colony formation. These results show both the importance of matrix attachment in regulating metabolic activity and an unanticipated mechanism for cell survival in altered matrix environments by antioxidant restoration of ATP generation.
Normal epithelial cells require matrix attachment for survival, and the ability of tumour cells to survive outside their natural extracellular matrix (ECM) niches is dependent on acquisition of anchorage independence 1 . Although apoptosis is the most rapid mechanism for eliminating cells lacking appropriate ECM attachment 2 , recent reports suggest that non-apoptotic death processes prevent survival when apoptosis is inhibited in matrix-deprived cells 3, 4 . Here we demonstrate that detachment of mammary epithelial cells from ECM causes an ATP deficiency owing to the loss of glucose transport. Overexpression of ERBB2 rescues the ATP deficiency by restoring glucose uptake through stabilization of EGFR and phosphatidylinositol-3-OH kinase (PI(3)K) activation, and this rescue is dependent on glucose-stimulated flux through the antioxidant-generating pentose phosphate pathway. Notably, we found that the ATP deficiency could be rescued by antioxidant treatment without rescue of glucose uptake. This rescue was found to be dependent on stimulation of fatty acid oxidation, which is inhibited by detachment-induced reactive oxygen species (ROS). The significance of these findings was supported by evidence of an increase in ROS in matrix-deprived cells in the luminal space of mammary acini, and the discovery that antioxidants facilitate the survival of these cells and enhance anchorage-independent colony formation. These results show both the importance of matrix attachment in regulating metabolic activity and an unanticipated mechanism for cell survival in altered matrix environments by antioxidant restoration of ATP generation.
Epithelial cells are dependent on interactions with specific ECM components for survival, proliferation and differentiation functions 5 . Loss of matrix attachment of cultured epithelial cells activates a caspase-mediated apoptotic program known as anoikis 2 . In glandular cancers, such as breast cancer, tumour cells are displaced from their normal matrix niches in the early stages of tumorigenesis when they proliferate into the lumen of hollow glandular structures. Filling of the luminal space is one of the hallmarks of early tumorigenesis.
Studies of luminal filling in three-dimensional (3D) structures of MCF-10A mammary epithelial cells and the developing mammary gland have demonstrated that apoptosis is involved in the clearance of centrally localized cells that lack matrix attachment; however, inhibition of apoptosis is not sufficient for the survival of matrix-deprived cells in the luminal space 3, 4, 6, 7 . Notably, several oncogenes, including ERBB2, have been shown to rescue cells from anoikis and prevent clearance of luminal cells in 3D acinar structures 8 , suggesting that these oncogenes prevent luminal clearance programs in addition to anoikis.
Another distinct feature of both matrix-detached MCF-10A cells and centrally located, matrix-deprived cells in MCF-10A acini is the induction of autophagy 9, 10 . Because autophagy is a catabolic process commonly upregulated under conditions of starvation 11 , the association of this process with matrix deprivation suggests that ECM attachment regulates metabolic activity as well as apoptosis. Here we determine the basis for the metabolic defects in matrix-detached cells, demonstrate that oncogenes can rescue these defects by restoration of glucose uptake and enhancement of antioxidant capacity, and unexpectedly find that antioxidants alone can rescue matrixdetached cells by restoration of ATP generation through fatty acid oxidation (FAO) . Furthermore, we demonstrate that antioxidants promote anchorage-independent survival in two in vitro models of tumorigenesis.
To investigate whether ECM regulates cellular metabolism, we examined cellular ATP levels in MCF-10A cells cultured on adherent or non-adherent plates. We detected a substantial reduction in ATP in both MCF-10A (Fig. 1a) and primary human mammary epithelial cells (HMEC; Supplementary Fig. 2 ) that had been detached from the ECM for 24 h. We confirmed these results in lysates normalized for total protein (Fig. 1b) and by measuring the ATP/ADP ratio (Fig. 1c) . The reduction of ATP in MCF-10A cells occurred between 12 and 24 h after ECM detachment ( Supplementary Fig. 7 ), was not affected by inhibition of apoptosis ( Fig. 1a and Supplementary Figs 4 and 5) or autophagy ( Supplementary Fig. 6 ), and was rescued by the addition of reconstituted basement membrane ( Supplementary Fig. 3 ). The expression of ERBB2 in these cells (ERBB2-MCF-10A) prevented the reduction in ATP after matrix detachment (Fig. 1a, c) , suggesting that ERBB2 circumvents the matrix requirement for ATP production.
Given the evidence that EGFR is downregulated in detached cells and that its overexpression can rescue anoikis 12 , we investigated the effect of ERBB2 on EGFR expression in detached cells. Indeed, ERBB2 expression caused a marked stabilization of EGFR after ECM detachment (Fig. 1d ) that was critical for the rescue of ATP (Fig. 1e) . This stabilization correlated with the maintenance of ERK1 and ERK2 (also known as MAPK3 and MAPK1, respectively) activation and an enhancement of PI(3)K-AKT signalling (Fig. 1d) ; however, inhibition of PI(3)K (but not ERK) abrogated the ERBB2 rescue of ATP (Fig. 1f, g ). Furthermore, expression of a constitutively active variant of PI(3)K (PIK3CA(E545K)) or AKT (Myr-AKT1) is sufficient to rescue detachment-induced ATP (Fig. 1h) . These results indicate that ERBB2 rescues the metabolic defect in matrix-detached cells by preventing the downregulation of EGFR and thus maintaining the activation of the PI(3)K pathway.
Given the critical role of PI(3)K-AKT in stimulating glucose transport 13, 14 , we investigated whether glucose uptake is altered in matrixdetached cells. Indeed, we found a marked deficiency in glucose uptake in detached cells that was rescued (in a PI(3)K-dependent fashion, Supplementary Fig. 8 ) by ERBB2 expression (Fig. 2a) . Furthermore, treatment of detached cells with methyl pyruvate, which provides substrates for the tricarboxylic acid (TCA) cycle, causes a substantial increase in ATP (Fig. 2b) that is blocked by the mitochondrial complex 1 inhibitor rotenone ( Supplementary Fig. 9 ). This suggests that the mitochondria of detached cells retain the capacity to produce ATP. To determine whether the rescue of glucose uptake by ERBB2 is important for its ability to increase ATP levels in detached cells, we treated ERBB2-MCF-10A cells with 2-deoxyglucose (2DG), a glucose analogue that inhibits glycolysis. 2DG treatment completely abolished the rescue of ATP by ERBB2 (Fig. 2c) , confirming the importance of glucose uptake in the rescue of ATP by ERBB2.
After cellular uptake, glucose can be further metabolised to generate ATP by glycolysis/oxidative phosphorylation, or it can be driven down the pentose phosphate pathway (PPP) by glucose-6-phosphate dehydrogenase (G6PD) 15 . Because the PPP is an important source of cellular NADPH (which provides reducing equivalents), we examined the effects of matrix detachment on ROS production. ECM detachment induced a significant increase in ROS (Fig. 2d) and decrease in reduced glutathione (Fig. 2e) , both of which were reversed by ERBB2 (Fig. 2d, f) . In support of the possibility that the lack of PPP flux is responsible for the increase in ROS, we found that the reduction in glucose uptake precedes the increase in ROS levels ( Supplementary  Fig. 10 ). Previous studies have shown that reducing ROS through the stimulation of PPP flux can promote cell survival 16, 17 ; thus we proposed that PPP flux may be important for ERBB2 to rescue ATP levels in detached cells. Indeed, the treatment of detached ERBB2-MCF-10A cells with the PPP inhibitors dehydroisoandrosterone (DHEA) or 6-aminonicotinamide (6AN) abrogated the ability of ERBB2 to rescue ATP (Fig. 2g) and led to an increase in cellular ROS ( Supplementary Fig. 11 ). Interestingly, we found that matrixdetachment caused a significant increase in G6PD protein (Fig. 2h) , and short interfering RNA (siRNA)-mediated reduction of G6PD in detached ERBB2-MCF-10A cells caused a substantial decrease in ATP levels (Fig. 2i) and increase in ROS (Fig. 2j) . The evidence that loss of matrix attachment causes an increase is ROS is consistent with studies in endothelial cells 18 and in the developing mammary gland 4 . The induction of ROS in suspended cells led us to investigate the effects of ROS neutralization on ATP in matrix-detached cells. Treatment of detached MCF-10A cells with the antioxidants N-acetyl-L-cysteine (NAC) or Trolox (a water-soluble vitamin E derivative) significantly increased ATP in detached cells (Fig. 3a) , independent of any changes in glucose uptake (Fig. 3b) . These data suggest that ROS inhibits ATP production through a metabolic pathway that could otherwise compensate for loss of glucose uptake.
It has previously been demonstrated that cancer cells deprived of glucose maintain ATP production through FAO 19 . Given that detached cells are glucose-deprived and antioxidants can promote ATP generation, we hypothesized that detachment-induced ROS could inhibit FAO. Indeed, we found that FAO was markedly reduced in detached MCF-10A cells (Fig. 3c) and Trolox treatment substantially increased FAO (Fig. 3d) . In addition, treatment of antioxidantsupplemented cells with etomoxir, an inhibitor of fatty acid transport into the mitochondria 19 , prevented the rescue of ATP by antioxidants in detached cells (Fig. 3e) . Furthermore, methyl malate treatment (which generates NADPH through an alternative pathway) increased ATP levels, lowered ROS levels, and caused an increase in FAO in detached MCF-10A cells ( Supplementary Fig. 12a-c) suggesting that NADPH production is sufficient to increase FAO. Notably, ERBB2 reduced FAO in attached and suspended cells (Fig. 3c) , consistent with previous reports showing PI(3)K-AKT-mediated reduction of FAO 19, 20 . However, treatment of detached ERBB2-MCF-10A cells with etomoxir caused a dose-dependent reduction in ATP levels (Fig. 3f) , suggesting that the residual FAO significantly contributes to ATP production in these cells.
To extend our analysis to a model with more physiological relevance, we used the MCF-10A 3D cell culture model in which the inner, matrix-deprived cells show evidence of metabolic impairment (on the basis of upregulation of autophagy 9, 10 ). Although it is not feasible to measure ATP directly in these structures, we used twophoton microscopy to examine the native fluorescence of NADH and NADPH (NAD(P)H) and obtain an assessment of metabolic differences between the inner and outer cells 21 . Because NADH is the principal electron donor in glycolytic and oxidative metabolism, the native fluorescence of NAD(P)H represents a non-invasive fluorescent reporter of the metabolic state 22 . Images of acinar structures on day 8 showed a dichotomy in NAD(P)H fluorescence intensity between the inner and outer cells of most structures, whereas most day 4 structures showed homogenous fluorescence ( Fig. 4a and Supplementary Fig. 13 ). Furthermore, we found that ROS were detectable exclusively in the centrally localized cells of day 7 acini (Fig. 4c) . Together, there results provide evidence that there are differences in metabolic activity and ROS accumulation in the matrix-deprived centrally localized cells of acini, as were observed in monolayer and suspension cultures (Figs 1-3 ). In addition, Trolox treatment prevented the dichotomy in NAD(P)H fluorescence in 3D culture ( Fig. 4b and Supplementary Fig. 14) , suggesting that ROS significantly contributes to the metabolic dichotomy between the inner and outer cells.
To understand the implications of these findings with regards to the clearance of cells from the luminal space, we studied the effects of antioxidant treatment on the survival of cells located in the centre of acini. We treated acini with either NAC or Trolox and monitored luminal filling over time. Notably, we found that NAC or Trolox treatment significantly reduced luminal clearance (Fig. 4d) independent of effects on caspase activation ( Supplementary Fig. 15 ), suggesting that the elimination of ROS can preserve the viability of matrix-deprived cells in the centre of acini. By extrapolation to our studies showing ATP reduction and ROS generation in matrixdeprived cells, we speculate that the viability is a consequence of rescuing these metabolic impairments. Furthermore, the late clearing of acini observed in BCL2-MCF-10A cells is suppressed by Trolox (Fig. 4d) . These results indicate that suppression of both metabolic impairments and apoptosis are required for anchorage-independent survival.
The evidence that antioxidants can rescue metabolic defects of ECM-deprived cells and promote luminal filling in MCF-10A acini raises the question of whether antioxidants could promote the transforming activity of mammary epithelial cells. To examine this, we assayed anchorage-independent colony formation in soft agar in MCF-10A cells expressing oncogenes that promote hyperproliferation (human papilloma virus E7 protein) and suppress apoptosis (BCL2). Neither E7 nor BCL2 expression rescued ATP in matrix detached cells LETTERS (data not shown) and the E7/BCL2 cells exhibited a relatively weak capacity to form colonies in this assay (Fig. 4e) . Trolox treatment induced a substantial increase in the number and average size of colonies, suggesting that antioxidant treatment can enhance the transforming activity of cells that contain oncogenic insults. We observed similar results with ERBB2-MCF-10A cells (Supplementary Fig. 16 ) and with BT-474 cells-an ERBB2-expressing breast cancer cell line ( Supplementary Fig. 17 ).
Our study highlights the possibility that glucose deprivation could lead to ROS production during tumorigenesis and force selection for alterations that allow escape from oxidative damage. Furthermore, we demonstrate that antioxidants rescue cells from the need for glycolysis through stimulation of FAO. It has been shown previously that stimulation of FAO through AMP-activated protein kinase (AMPK) or p53 (also known as TP53) is another mechanism for the survival of cells in the absence of glucose 19 . Thus, our study suggests that deprivation of matrix may limit glucose accessibility during tumorigenesis, and reveals strategies in which a tumour could escape from metabolic stress owing to these conditions by stimulating anchorage-independent glucose transport and/or eliminating ROS. These data also demonstrate that antioxidants promote the survival of cells that lack attachment to the ECM and raise the possibility that antioxidants may have dichotomous activities with respect to tumorigenesis-that is, suppressing tumorigenesis by preventing oxidative damage to DNA 23, 24 , and promoting tumorigenesis by allowing survival of cells that are metabolically impaired (for example, in altered matrix environments). In support of this, expression of SOD2, a mitochondrial protein that reduces oxidative stress caused by respiratory chain leak, is increased in more advanced and higher grade mammary tumours 25, 26 . Furthermore, a recent study has revealed that enhanced PPP flux and increased antioxidant capacity correlates with metastasis of breast cancer cells to the brain 27 . Lastly, randomized trials have demonstrated both anti-neoplastic and neoplastic effects of antioxidants, with neoplastic effects associated with patients at higher risk owing to smoking and alcohol consumption 28 , or patients undergoing chemo-or radiation therapy 29 . Our work provides a biological rationale for these findings, as antioxidant activity may promote the survival of pre-initiated tumour cells in unnatural matrix environments and thus enhance malignancy.
METHODS SUMMARY
MCF-10A cells and their variants were all cultured as described at http://brugge. med.harvard.edu/. Other cell lines were cultured as described in the Supplementary Information. All assays on ECM-detached cells were carried out 24 h after plating on poly(2-hydroxyethyl methacrylate) (poly-HEMA)-coated plates unless otherwise noted. ATP assays were conducted using the ATPlite assay (PerkinElmer), the ATP determination kit (Invitrogen), or the ATP/ADP Ratio Assay Kit (BioAssay Systems). Glucose uptake assays were performed using the Amplex Red Glucose Assay Kit (Invitrogen). ROS was measured using carboxy-H 2 DCF-DA in detached/attached cells and in 3D culture. To measure reduced glutathione, we used chloromethylcoumarin (CMAC, Invitrogen). FAO was measured by monitoring the release of 14 CO 2 after the addition of 1-14 C-oleic acid. The 3D culture of mammary acini was completed according to the protocol at http://brugge.med.harvard.edu/. Native fluorescence of NADPH was measured using two-photon microscopy. Soft agar assays were performed in the presence or absence of antioxidants and colony formation/size was determined using ImageJ.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Cell culture. MCF-10A cells were cultured as described previously 30 and at http://brugge.med.harvard.edu/. MCF-10A cells expressing BCL2, ERBB2, E7/ BCL2, PIK3CA(E545K), Myr-AKT1, IGF1R or GFP-LC3 were generated as described previously 3 . The pMSCV-Neo-based retroviral vectors encoding wild-type human IGFIR complementary DNA was a gift from R. Baserga. HMEC cells were immortalised with human TERT and cultured as described previously 31 . BT-474 cells (ATCC) were cultured in RPMI 1640 media plus 10% FBS and penicillin/streptomycin. ATP assays. For the comparison of ATP levels in detached versus attached cells, the ATPlite assay (PerkinElmer) was used. Cells were plated in 96-well poly-HEMA-coated (or uncoated) plates at a density of 13,333 cells per well. After 24 h, ATP assay was conducted according to the manufacturer's protocol. For the measure of ATP in detached cells (normalized by protein content), the ATP determination kit (Invitrogen) was used. Cells were plated in 6-well poly-HEMA-coated plates at a density of 400,000 cells per well. After 24 h, cells were lysed in 1% NP40 (plus protease inhibitors) and lysates were normalized by protein content using BCA Protein Assay (Pierce Biotechnology). Lysates were then tested for ATP levels according to manufacturer's protocol. The data from these assays show representative experiments from more than three independent replicates. For determination of the ATP/ADP ratio, the ADP/ATP Ratio Assay Kit (BioAssay Systems) was used according to manufacturer's instructions. The data from the ATP/ADP assay is presented as an average of the ATP/ADP ratio from several experiments. 3D cell culture. To generate acini, cells were grown in reconstituted basement membrane (Matrigel) as described previously 30 and according to the protocol at http://brugge.med.harvard.edu/. For antioxidant treatment, either NAC or Trolox was added to the Matrigel and to the overlay media. Immunofluorescence of acini was performed as described previously 30 . The following primary antibodies were used for immunofluorescence: cleaved caspase-3 (Cell Signaling Technology) and laminin-5 (Millipore). DAPI (Sigma-Aldrich) was used to counterstain nuclei. For examination of luminal filling, acini were imaged using confocal microscopy to visualize the centre of each structure, and then were scored as clear (,90-100% clear), mostly clear (,50-90% clear), mostly filled (,10-50% clear), or clear (,0-10% clear). The figures including data from these assays show representative experiments from more than three independent replicates. Reagents. The following reagents were used at the doses indicated and as described in the text/figure legends: methyl pyruvate (Sigma-Aldrich), 2-deoxy-D-glucose (Sigma-Aldrich), DHEA (EMD Biosciences), 6AN (Sigma-Aldrich), N-acetyl-L-cysteine (Sigma-Aldrich), Trolox (EMD Biosciences), etomoxir (Sigma-Aldrich), D-methyl malate (Sigma-Aldrich), Matrigel (BD Biosciences), poly(2-hydroxyethyl methacrylate) (poly-HEMA, Sigma-Aldrich), LY294002 (EMD Biosciences), U0126 (EMD Biosciences), staurosporine (Sigma-Aldrich), and DL-buthionine-(S,R)-sulphoximine (BSO, Sigma-Aldrich). siRNA. The following siRNA SMARTpools (Dharmacon) were used: G6PD (M
